Log in to save to my catalogue

Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus

Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8605611

Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus

About this item

Full title

Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Endocrinology, 2021-11, Vol.17 (11), p.685-697

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Fracture risk is increased in patients with type 2 diabetes mellitus (T2DM). In addition, these patients sustain fractures despite having higher levels of areal bone mineral density, as measured by dual-energy X-ray absorptiometry, than individuals without T2DM. Thus, additional factors such as alterations in bone quality could have important roles...

Alternative Titles

Full title

Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8605611

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8605611

Other Identifiers

ISSN

1759-5029

E-ISSN

1759-5037

DOI

10.1038/s41574-021-00555-5

How to access this item